ARCHIVES

NCI Plans Progress Review In Lymphoma This Year.

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | March 10, 2000

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

“Realistic” Bypass Budget For 1983 asks $1.147Billion; Organ Site, Training, Control Would Get No Increases

September 18, 1981

NCI contract Award

August 1, 1997

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001